Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses
Health Policy Watch reported that the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium, provides scientists with starting points to advance the development of tools that can tackle several priorities set out by the WHO. “Efforts to end infectious diseases will only succeed if we have the tools to treat and prevent them,” said Dr Timothy Wells, MMV’s Chief Scientific Officer. “Open innovation is one of the keys to unlocking drug discovery because it allows us to tap into existing knowledge and expertise and build on it collaboratively,” said Wells.
Click here to read the full article.